Access decisions are shaped not only by national and international processes and by the methods used to generate and present evidence described in other sections, but also by the wider industry and societal context in which therapies are developed, assessed and used. Policy direction, public expectations, scientific and manufacturing advances, and evolving standards for conduct and communication can all influence what decision makers look for and what industry needs to deliver.
This section brings together a set of cross-cutting key topics that sit alongside the core access workflow. The linked Briefings provide concise context and practical implications, helping access professionals to stay informed on developments that may affect evidence expectations, engagement approaches, and the options available for access strategy and implementation.
If you would like to consult our Briefings please login at the top of the page or investigate subscription options by clicking on the button below:
In this section free members and paid subscribers can consult descriptions of selected key topics, with links to sources of additional information:
- Patient participation in access
- Advanced Therapy Medicinal Products (ATMPs)
- Medicines and the environment